Table 3.
AMC criteria | Weights | ||
---|---|---|---|
Estimated proportion of resistance to this antimicrobial/group of antimicrobials in infections by relevant pathogens in the population over the next 5 years | 0.44 |
Very low Low Medium High |
< 1% 1–10% 10–99% > 99% |
Estimated impact of resistance to this antimicrobial/group of antimicrobials of relevant human pathogens on the affected population over the next 5 years (morbidity, mortality) | 0.39 |
Very low Low Medium High |
< 1% 1–10% 10–99% > 99% |
Perceived or known percentage of prescriptions with misuse/overuse of this antimicrobial/group of antimicrobials (consumption reflects misuse/overuse and thus amenable to interventions) | 0.17 |
Very low Low Medium High |
< 1% 1–10% 10–99% > 99% |
AMR criteria | Weights | ||
---|---|---|---|
Estimated incidence of infections by this resistant microorganism in the relevant population (hospital, community or total) over the next 5 years | 0.42 |
Very low Low Medium High |
< 1 per 100,000 population* 1–100 per 100,000 population* 100–1,000 per 100,000 population* > 1,000 per 100,000 population* |
Estimated impact of infections by this resistant microorganism in the relevant population (hospital, community or total) over the next 5 years (morbidity, mortality) | 0.37 |
Very low Low Medium High |
< 1% 1–10% 10–99% > 99% |
Perceived or known percentage of resistance of this microorganism linked to human‐to‐human transmission (reflects infection control practice and thus amenable to interventions) | 0.21 |
Very low Low Medium High |
< 1% 1–10% 10–99% > 99% |
Population*: refers to inhabitants or admissions, respectively, for the community and hospital populations.